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Corticotherapy is a common treatment in mares susceptible to endometritis. Iso-
ﬂupredone improves pregnancy rates and affects the protein proﬁle of endometrial ﬂuid
in comparison to untreated mares. Dexamethasone decreases postbreeding ﬂuid accu-
mulation and uterine edema; however, its effects on the protein proﬁle of the endometrial
ﬂuid have not yet been studied. The aim of the present study was to verify the effect of
dexamethasone on the protein proﬁle of endometrial ﬂuid, in the presence or absence of
infection, from mares susceptible to persistent postbreeding endometritis. Nine suscep-
tible mares aged between 7 and 18 years were used. After checking for signs of estrus,
mares were subjected to four treatments: C: mares received no treatment and served as
control; D: mares received 40-mg dexamethasone at breeding, with collection of samples
after 6 hours; I-6 and I-24: intrauterine infusion of 1  109 Streptococcus zooepidemicus/
mL and samples collected after 6 and 24 hours; I/D-6 and I/D-24: intrauterine infusion of
1  109 S zooepidemicus/mL and 40-mg dexamethasone, collecting the sample after 6 and
24 hours. All mares were subjected to all treatments. Samples were collected and sub-
jected to two-dimensional electrophoresis and mass spectrometry for the identiﬁcation of
relevant protein spots. Corticotherapy altered the protein proﬁle of the endometrial ﬂuid
of susceptible mares, characterized by an increase and/or decrease in the optical density
of inﬂammatory acute-phase proteins. We conclude that the use of dexamethasone in
mares with and without infection alters the protein proﬁle of endometrial ﬂuid of sus-
ceptible mares.
 2015 Elsevier Inc. All rights reserved.1. Introduction
Endometritis is a major cause of reduced fertility in
brood mares and has a signiﬁcant economic impact on the
equine industry [1]. In the normal mare, the uterus is well
protected from external contamination by physical barrier
consisting of the vulva, the vestibule, the vagina, and the
cervix and any factor that compromises these barriers may
predispose the mare to a chronic uterine infection [2].; fax: þ 55 51 3308
. All rights reserved.
9Streptococcus equi subsp. zooepidemicus (S zooepidemicus) is
the pathogen most commonly isolated from the uterus of
mares with endometritis [3]. However, the most common
form of endometritis is that induced by breeding [4].
An inﬂammatory response occurs after the introduction of
spermatozoa into the uterine lumen and is dependent on
sperm concentration [5,6]. Rather than be considered a
pathologic condition, mating-induced endometritis is
likely to be a physiological reaction that removes excess
spermatozoa, seminal plasma, and possible bacterial
contamination from the uterus [1]. When the embryo de-
scends from the oviduct on Day 5 after ovulation, its sur-
vival depends on the uterus being free of inﬂammation [7].
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are considered susceptible to this condition [5].
Glucocorticoids are well-recognized anti-inﬂammatory
and immunomodulatory agents [8]. Corticotherapy has
been proposed to modulate the uncoordinated uterine in-
ﬂammatory response, increasing pregnancy rates of sus-
ceptible mares with the use of isoﬂupredone before
insemination [9,10]. However, administration of a unique
dose of dexamethasone (10–20 mg) used after insemination
did not improve pregnancy rates [11]. A single dose of
dexamethasone (0.1 mg/kg) administered at the time of
breeding reduces postmating efﬂux turbidity and endome-
trial edema and can be used to modulate the uterine in-
ﬂammatory response to breeding in susceptible mares [12].
Nevertheless, the use of 40-mg dexamethasone 2 hours
before breeding was not able to reduce ﬂuid accumulation
10 and 26 hours later in susceptible and resistantmares [13].
Dexamethasone and isoﬂupredone acetate present
pharmacologic differences. Both are glucocorticoids with
peaks from 1 to 2 hours, but while dexamethasone has a
half-life from 36 to 54 hours [14,15], isoﬂupredone acetate
has a half-life from 12 to 36 hours [15]. Dexamethasone has
an elimination half-life from 3 to 6 hours, with renal
excretion [16]. In a previous study of our group, it was
shown that the use of isoﬂupredone altered the endome-
trial ﬂuid proteomics of mares susceptible to endometritis,
[17]. However, the protein proﬁle of endometrial ﬂuid of
mares treated during estrus with dexamethasone has not
yet been studied.
The aim of the present study was to analyze the effect of
dexamethasone on the protein proﬁle of endometrial ﬂuid
in the presence or absence of infection from mares sus-
ceptible to persistent postbreeding endometritis.
2. Materials and methods
2.1. Mares
Eight Criollo and one CriolloThoroughbredmixed-breed
mares (7–18 years old) weighing on average 400 kg (380–
430 kg) were used. Mares were susceptible to endometritis,
with endometrial status varying from IIb (n ¼ 7) and III
(n¼ 2) [18], cyclic, and clinically healthy. Susceptibility was
determined after artiﬁcial insemination with 500  106
sperm cells diluted in skim milk (ﬁnal volume, 20 mL) ac-
cording to Malschitzky et al. [19]. Mares with intrauterine
ﬂuid accumulation greater than 15 mm in diameter (on the
basis of ultrasonographic examination of the uterus 36–
48 hours after AI) were classiﬁed as susceptible. These
mares were part of an experimental herd and maintained
in an open ﬁeld, supplemented with oats and alfalfa hay,
with ad libitum access to water. This study was carried out
with an Animal Ethical Use Committee–approved protocol
at the Universidade Federal do Rio Grande do Sul, Porto
Alegre, Rio Grande do Sul, Brazil (protocol number 23555
from September 3, 2012).
2.2. Reproductive management
Mares were examined daily until estrus was detected by
transrectal palpation and ultrasonographic examination ofthe reproductive tract. Once estrus was conﬁrmed (ovarian
follicle >35 mm in diameter and marked uterine edema),
mares were subjected to four treatments (carried out
consecutively, every second estrus period). To ensure that
all mares were in estrus at sample collection, they were
routinely examined by transrectal palpation and ultraso-
nographic examination of the reproductive tract at 12-hour
intervals to detect ovulation. If a mare ovulated during
treatment, these data were not used.
Before starting each treatment, clinical examinations of
the genital tract and endometrial cytology, using a guarded
swab, was performed on all mares to ensure that there was
no preexisting endometritis. Only mares without cytologic
evidence of endometritis (absence of polymorphonuclear
neutrophils in the slide at magniﬁcation: 400) were used.
2.3. Control treatment (C)
Mares did not receive any treatment.
2.4. Dexamethasone (D)
Mares were given 40-mg dexamethasone sodium
phosphate intravenously (Cortivet; UCB, Jaboticabal, Brazil)
in a single standard dose. A 40-mg dose was used in this
study, calculated for a 400-kg mare, at 0.1 mg/kg, and
administrated when the animal was conﬁrmed in estrus.
Samples were collected 6 hours after dexamethasone
administration.
2.5. Experimental infection (I)
Mares were antiseptically infused with 1  109 colony-
forming units (CFUs) of S zooepidemicus/mL suspended in
20-mL saline (0.9%) solution. When estrus was conﬁrmed,
an insemination pipette was used to infuse the suspension
into the uterus [20]. Samples were collected 6 (I-6) and 24
(I-24) hours after uterine infusion.
Streptococcus equi subsp. zooepidemicus was isolated
from a mare with clinical signs of endometritis. After
isolation, bacteria were cultured in brain heart infusion
(BHI) media for 24 hours. Glycerol was added to the bac-
teria in BHI bouillon and placed in 2.0-mL vials (Eppendorf
do Brasil, São Paulo, SP, Brazil), which were put directly into
a 20 C freezer. Before infusion, bacteria were thawed in a
water bath at 37 C, cultured in BHI for 24 hours (37 C), and
seeded onto 100-mm blood agar dishes (20–30 dishes).
Dishes were incubated at 37 C for 24 hours to allow bac-
terial growth. Dishes were washed with PBS, and bacterial
colonies were carefully removed. The resulting bacterial
suspension was then ﬁltered to remove agar particles and
resuspended in PBS to a ﬁnal concentration of 1 109 CFU/
mL. The suspension was placed in 20-mL vials and kept at
5 C until use.
2.6. Experimental infection þ dexamethasone (I/D)
Mares were infused with S zooepidemicus and treated
with 40-mg dexamethasone intravenously when estrus
was detected and as described previously. Sample
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after uterine infusion.
2.7. Experimental design
The study was carried over 150 days during the
breeding season. All mares (N ¼ 9) were submitted to all
four treatments (C, D, I, and I/D described previously), and
between each treatment, they had at least one estrous cycle
interval. In all mares, the ﬁrst estrus was used for
the control (C) treatment, the third estrus for dexametha-
sone (D) treatment, the ﬁfth estrus for experimental
infection (I), and the seventh estrus for experimental
infection þ dexamethasone (I/D). Before all transvaginal
manipulations, the mare’s tail was wrapped and the peri-
neal region was cleaned with water, neutral detergent, and
degermant solution (Laboriodine; Segmenta, Ribeirão
Preto, São Paulo, Brazil) and dried with a paper towel.
To ensure that inﬂammation was absent before starting
the next treatment, at the end of the last sample collection,
mares underwent uterine washing and intrauterine infu-
sion of 10  106 IU penicillin (Novapen; Marcolab, São João
do Paraíso, Minas Gerais, Brazil) for 5 days. Mares were
monitored on the basis of absence of neutrophils in a
uterine swab and the absence of uterine ﬂuid
accumulation.
2.8. Sample collection
Samples were collected using commercial vaginal tam-
pons (Mini OB; Johnson & Johnson Industrial Ltda, São José
dos Campos, São Paulo, Brazil). Tampons were antisepti-
cally introduced into the uterus, according to Reilas [21],
modiﬁed by Malschitzky et al. [19]. The tampon was
inserted through the cervix, protected by a palpation glove
(double-glove technique). The distal part of a palpation
glove was cut to form a plastic tube, and the gloved hand
with the tamponwas introduced in the plastic tube, closing
its end with a ﬁnger. The plastic tube was removed at the
moment of the tampon’s introduction in the uterus, where
it remained for 30minutes. The tamponwas then removed,
protected by a palpation glove, and immediately inserted in
a sterile plastic sack and centrifuged (1500  g, for 10 mi-
nutes) for ﬂuid recovery. The recovered ﬂuid (>0.5 mL) was
transferred to conic tubes and immediately centrifuged at
4 C (1000 g, for 1 hour). The supernatant was transferred
to cryovials in 2-mL aliquots, which were stored in a freezer
at 80 C until further analyses.
2.9. Electrophoresis
Protein content was determined according to Lowry
et al. [22], using 1mg/mL of BSA (A7906; Sigma–Aldrich, St.
Louis, MO, USA) as standard.
Uterine ﬂuid proteins were separated using two-
dimensional gel electrophoresis in duplicate as described
by Görg et al. [23], modiﬁed by Van Tilburg et al. [24].
In summary, samples containing 200 mg of total protein
were mixed with buffer (7-M urea, 2-M thiourea), 2% free
ampholytes (IPG buffer, pH 3–10 [GE Life Sciences,
Piscataway, NJ, USA]), 2% dithiothreitol (DTT), 2% CHAPS,and traces of bromophenol blue sufﬁcient to reach a vol-
ume of 250 mL. Then, samples were incubated in 7-cm IPG
Strips (pH 3–10 linear, GE Life Sciences) and allowed to
rehydrate for 16 hours at room temperature. Isoelectric
focusing was carried out in Protean IEF Cell (Bio-Rad) with
the following conditions: 100 Volts (V; 100 Volts hour
[Vh]), 500V (250Vh), 1000 V (250Vh), 4000 V (2000 Vh),
4000 V (20,000 Vh). After focusing, strips containing
endometrial proteins were incubated during 20 minutes
in equilibration buffer I (50-mM Tris-HCl, pH 8.8, con-
taining 6-M urea, 29.3% glycerol, 2% SDS, 2% DTT) and
reequilibrated for an additional 20 minutes in buffer II
(similar to buffer I, but containing 2.5% iodoacetamide
instead of DTT).
Polyacrylamide gels were prepared between two glass
plates in the Mini-PROTEAN (Bio-Rad) system. After
equilibration, strips were ﬁxed with agarose (5% in SDS-
PAGE running buffer) on the top of homogeneous SDS-
polyacrylamide gels (12%). The running buffer contained
12-mL acrylamide, 4-mL SDS 1%, 0.375-M Tris-HCl (pH 8.8),
3-mL glycerol,11-mLMilli-Qwater,17.5-mL TEMED, and 125-
mL ammonium persulfate. Electrophoresis was performed
at a maximum of 125 V and 20 mA (Electrophoresis Power
Supply 301; Amersham Pharmacia Biotech) per plate dur-
ing 2.5 hours.
Gels were stained in colloidal Coomassie blue [25] with
modiﬁcations [24]. Brieﬂy, gels were washed three times
(20 minutes each) in a solution containing phosphoric acid
(2%) and ethanol (30%); another three washes in 2% phos-
phoric acid, and then put in a solutionwith phosphoric acid
(2%), ethanol (18%), and ammonium sulfate (15%) added
with 1 mL of a Coomassie Blue G-250 solution (2%) for
36 hours. Gels were washed with distilled water and stored
at 5 C. Reagents used for electrophoresis were purchased
from Bio-Rad, Sigma–Aldrich, and GE Life Sciences.
Two-dimensional gels were scanned (Hewlett-Packard
6100C, Palo Alto, CA, USA), saved as tagged image ﬁle
format (.tiff) ﬁles, and analyzed to determine relative pro-
tein content of the spots expressed in pixels using PDQuest
software (version 8.0.1, Bio-Rad). Two-dimensional maps
were evaluated in a single-match set, and a master gel was
generated on the basis of a representative gel. In addition,
spots consistently present in the remaining gels were
added to the master, so that they could be matched to all
samples. Proteins in key regions of the master gel were
used as landmarks, and ﬁnal spot matches were organized
by checking each spot in each gel with the respective
pattern in the master. The software created a histogram of
all pixels in the image, deﬁning the distribution of the
pixels as a function of the intensity. The histogram then
determined the level of gray used to display each pixel in
the image. Protein content of the spots was expressed as
relative percentage, considering 100% the total of the spots
(in pixels). Each protein spot was a percentage of the total.
A systemwas applied to assign a number to each spot, and a
map of the proteins present was prepared. Each spot
frequency was assessed in all gels, and the presence or
absence of the spot was determined. Frequency was
expressed as a percentage of the gels in which the spot was
present, as a function of the total number of gels in each
treatment.
Fig. 1. Two-dimensional polyacrylamide electrophoretic gel of equine
endometrial ﬂuid. Identiﬁed proteins (gene name and spot number) showed
signiﬁcant difference (P < 0.05) among the groups. Alb, albumin; Apo A1,
apolipoprotein A1; TTR, transthyretin.
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Protein identiﬁcation was determined by mass spec-
trometry. Statistically relevant (with respect to their rela-
tive optic density and frequency) protein spots were
excised from the gel and digestedwith trypsin, as described
by Shevchenko et al. [26]. Peptide sequencing was per-
formed in the Uniprote-MS laboratory, at the Centro de
Biotecnologia from Universidade Federal do Rio Grande do
Sul, using a nanoscale separation system (UPLC nano-
ACQUITY; Waters, Milford, MA, USA) connected to a mass
spectrometer (Q-TOF Micro; Waters). Sequences were
compared for correspondence in a data bank (http://www.
swissprot.com).
2.11. Protein gene ontology analysis
To discover gene ontology categories, the mass
spectrometry–identiﬁed proteins were processed by the
software Strap 1.5 (Cardiovascular Proteomics Center, Bos-
ton University School of Medicine) freely available at http://
www.bumc.bu.edu/cardiovascularproteomics/cpctools/
strap/.
2.12. Statistical analysis
A one-way ANOVA was performed to evaluate the
relative optical density of each protein spot as a dependentFig. 2. Relative protein content (%) of protein spots indentiﬁed in the experimental
collection at 6 (I-6) and 24 hours (I-24), and experimental infection with dexam
represent signiﬁcant differences (P < 0.05). TTR, transthyretin (spots 1701 and 230factor and the experimental treatments as independent
variables. The Tukey post hoc test was used to locate dif-
ferences, and P < 0.05 was regarded as signiﬁcant. At least
two good resolution gels per sample were used. The fre-
quency of protein spots was determined by the chi square.3. Results
All mares infused intrauterine with S zooepidemicus
showed signs of clinical endometritis before sample
collection, characterized by accumulation of intrauterine
ﬂuid (>15 mm, as determined by transrectal
ultrasonography).
Good-quality resolution gels were analyzed, identifying
43 protein spots, with isoelectric points from 4.3 to 10.0
and molecular weight from 15 to 105 kDa. Among the
identiﬁed spots observed, six presented signiﬁcant differ-
ences between treatments (Fig. 1).
Corticotherapy in the presence of infection increased the
abundance of two spots (1701 and 2302) when compared to
their abundance in the uterine ﬂuid of mares treated with
dexamethasone. Both spotswere identiﬁed as transthyretin
(TTR; Fig. 2). However, no differences in the abundance of
the protein spots were observed in the ﬂuid from mares
infected at 6 and 24 hours (I-6 and I-24) when compared
with the ﬂuid from infected mares treated with dexameth-
asone at 6 and 24 hours (I/D-6 and I/D-24). Dexamethasone
treatment reduced the abundance of apolipoprotein A1
(Apo A1; spot 1401) in the endometrial ﬂuid in relation to
the abundance in the control group (Fig. 3).
Uterine infection provoked an increase (P < 0.05) in the
abundance of two albumin forms (spots 4801 and 5901)
and actin (spot 5601) in relation to the control group
(Fig. 4). No differences regarding frequency of protein spots
were observed between treatments.
The gene ontology categories of the statistically relevant
proteins identiﬁed in the endometrial ﬂuid from suscepti-
ble mares are described in Table 1.4. Discussion
In this study, dexamethasone in the presence of uterine
infection provoked an increase in TTR optic density when
compared to that observed in mares treated withgroups control (C), dexamethasone (D), experimental infection with sample
ethasone treatment at 6 (I/D-6) and 24 hours (I/D-24). a,bDifferent letters
2).
Fig. 3. Relative protein content (%) of protein spots indentiﬁed in the
experimental groups control (C), dexamethasone (D), experimental infection
with sample collection at 6 (I-6) and 24 hours (I-24), and experimental
infection with dexamethasone treatment at 6 (I/D6) and 24 hours (I/D24).
a,bDifferent letters represent signiﬁcant differences (P < 0.05). ApoA1,
apolipoprotein AI (spot 1401).
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thyroxine (T4) and retinol (vitamin A), forming a macro-
molecular complex with lipocalin retinol-binding protein
in the latter [27,28]. Besides its transport activities, TTR is a
protease that is able to cleave Apo A1 in its C terminus. Its
binding proteolytic activity is abolished when TTR com-
plexes with the ligand retinol-binding protein, whereas
binding T4 has minimal impact on TTR proteolytic activity
[28,29]. Transthyretin was also found to be associated with
lipoproteins, in particular the high density lipoproteins
fraction. The interaction of TTR with the high density li-
poproteins particle occurs via Apo A1 [30].
The increase in TTR, detected in this experiment in the
group of infected mares treated with dexamethasone, was
similar to that observed by Wolf [17] using isoﬂupredone.
An increase in the expression of TTR is inﬂuenced by the
use of hydrocortisone [31] and by infectious diseases. Thus,
some studies describe the increase of TTR due to tubercu-
losis in bovine [32] and humans [33].
It is possible that TTR cleaving Apo A1 promotes the
inhibition of the IL-1b. This potent proinﬂammatory cyto-
kine released as inﬂammation begins [34] and inhibited by
Apo A1 [35] reported lower gene expression in mares 3
hours after dexamethasone treatment concurrent with an
Escherichia coli infusion compared to mares infected but
not treated [36]. Dexamethasone administered during anFig. 4. Relative protein content (%) of protein spots indentiﬁed in the experimental
collection at 6 (I-6) and 24 hours (I-24) and experimental infection with dexametha
signiﬁcant differences (P < 0.05). ACT, actin (spot 5601); ALB, albumin (spots 5901inﬂammatory process diminished the expression of IL1b
messenger RNA 6 hours after treatment [37]. An immune-
modulatory effect of TTR may occur due to the cleavage of
Apo A1 and the inhibition of IL-1b.
In the study performed by Wolf et al. [17], besides the
increase in TTR, isoﬂupredone decreased transferrin and
increased a1-antitripsin in mares with uterine infection. In
the present experiment, the expression of a1-antitripsin
and transferrin using dexamethasone showed no signiﬁ-
cant differences among groups. In clinical trials, the use of
isoﬂupredone in susceptible mares increased their preg-
nancy rates when compared to control mares [9,10]. The
use of a single dose of dexamethasone administered at the
time of breeding in susceptible mares reduces postmating
efﬂux turbidity and endometrial edema after breeding [12].
However, the administration of dexamethasone in a single
dose 6 to 12 hours after insemination did not improve
pregnancy rate when compared to controls regardless of
age or the presence of intrauterine ﬂuid [11].
The differences in the protein proﬁle observed between
treatments with dexamethasone and isoﬂupredone acetate
can be explained by their pharmacologic differences.
Furthermore, the glucocorticoid tissue penetration and the
duration of the effect are inﬂuenced by the chemical
structure. Esters with moderate insolubility, such as ace-
tates, allow for their maintenance due to a relatively long
half-life in the organism [38]. Therefore, the use of iso-
ﬂupredone acetate each 12 hours from estrus detection
until ovulation probably achieves a longer effect when
compared with a single dose of dexamethasone at
breeding. Therefore, a dexamethasone higher administra-
tion frequency could be beneﬁcial for the treatment of
uterine infectious processes.
In this experiment, a rise of the actin abundance was
observed from 6 to 24 hours after infection. Actin is the
main component of the cellular cytoskeleton, and it is
present in every eukaryote cell [39]. Its presence can
either indicate local damage or higher neutrophil migra-
tion [40] and can be used as a marker in inﬂammatory
processes [41]. An intact cytoskeleton is essential for cell
motility and activation [42], and actin remodeling is
crucial for neutrophil movement [43]. Because of the rapid
reorganization of actin, neutrophils can orient their
migration and exhibit chemotactic movement, enabling
them to accumulate at injury sites. There is evidence thatgroups control (C), dexamethasone (D), experimental infection with sample
sone treatment at 6 (I/D6) and 24 hours (I/D24). a,bDifferent letters represent
and 4801).
Table 1
Gene ontology analysis of the statistically relevant proteins identiﬁed in
the endometrial ﬂuid from susceptible mares processed by the software
Strap 1.5.
Protein Biological process Molecular
function
Cellular
component
Albumin Cellular process
Regulation
Binding Extracellular
Macromolecular
complex
Cytoplasm
Actin d Binding Cytoskeleton
Transthyretin Cellular process
Localization
Regulation
Binding Extracellular
Macromolecular
complex
Cytoplasm
Apolipoprotein
A1
Cellular process
Metabolic process
Developmental
process
Localization
Regulation
Interactions with
cells and organisms
Binding
Enzyme
regulation
activity
Extracellular
Endosome
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ﬂammatory response, by decreasing nitric oxide produc-
tion, prostaglandin E2 release [44], and probably TNF-a
secretion [45]. Abundant presence of actin in infected sites
may be used by the immune system to enhance spatio-
temporal immunity in an attempt to arrest infection and
control inﬂammation [46]. However, the immunomodu-
latory action veriﬁed with the increase in the abundance
of actin after treatment with isoﬂupredone [17] was not
observed in the present experiment. The dose or fre-
quency of treatment with dexamethasonemay explain the
different results. Therefore, a dexamethasone higher
administration frequency could be beneﬁcial for the
treatment of uterine infectious processes.
Albuminwas increased at 6 and 24 hours after infection
when comparedwith controls in the present study and also
an increase 24 hours after the infection in relation to
6 hours. Increased albumin levels in the cerebrospinal ﬂuid
were found in patients with infectious meningitis
compared to healthy controls [47] and also increased syn-
thesis by the mammary gland of mastitic cows when
related to healthy glands [48]. Concentrations of serum
albumin in milk increase during mammary involution [49]
and during inﬂammation [50] inﬂuencing the function of
the milk–blood barrier. In mares with chronic metritis, al-
bumin concentrations were signiﬁcantly elevated in uter-
ine secretions caused by a local synthesis or due to active
transport to the uterus [51].
The biological process showed that the identiﬁed pro-
teins were involved in developmental and cellular pro-
cesses, as well as in regulation, localization, and in
interactions with cells and organisms process. The func-
tional annotation showed that identiﬁed proteins were
implicated in few molecular functions. The most abundant
were binding proteins and proteins with enzyme regula-
tion activity. The cellular component shows that most of
the identiﬁed proteins were extracellular, from the cyto-
plasm, cytoskeleton, endosome, and the macromolecular
complex.In conclusion, the use of dexamethasone in mares with
and without infection altered the protein proﬁle of the
endometrial ﬂuid of susceptible mares. Dexamethasone in
the presence of infection provoked an increase in TTR
enhancing the defense mechanism and protection of
inﬂamed tissue. In clinically healthy susceptible mares,
dexamethasone decreased the abundance of Apo-A1.
Additionally, uterine lumen infection altered proteomics
of the endometrial ﬂuid, characterized by a variation in
actin and albumin.
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